461 related articles for article (PubMed ID: 29991134)
1. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
Kent BA; Strittmatter SM; Nygaard HB
J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134
[TBL] [Abstract][Full Text] [Related]
2. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
Jyoti A; Plano A; Riedel G; Platt B
J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and EEG changes in male 5xFAD mice.
Schneider F; Baldauf K; Wetzel W; Reymann KG
Physiol Behav; 2014 Aug; 135():25-33. PubMed ID: 24907698
[TBL] [Abstract][Full Text] [Related]
4. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
5. Alteration of cortical EEG in mice carrying mutated human APP transgene.
Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
[TBL] [Abstract][Full Text] [Related]
6. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
8. Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F).
Del Percio C; Drinkenburg W; Lopez S; Limatola C; Bastlund JF; Christensen DZ; Pedersen JT; Forloni G; Frasca A; Noe FM; Bentivoglio M; Fabene PF; Bertini G; Colavito V; Dix S; Ferri R; Bordet R; Richardson JC; Babiloni C
Curr Alzheimer Res; 2018; 15(3):259-272. PubMed ID: 28675996
[TBL] [Abstract][Full Text] [Related]
9. Delayed daily activity and reduced NREM slow-wave power in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Kent BA; Michalik M; Marchant EG; Yau KW; Feldman HH; Mistlberger RE; Nygaard HB
Neurobiol Aging; 2019 Jun; 78():74-86. PubMed ID: 30884411
[TBL] [Abstract][Full Text] [Related]
10. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
[TBL] [Abstract][Full Text] [Related]
11. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
12. Progressive age-related changes in sleep and EEG profiles in the PLB1Triple mouse model of Alzheimer's disease.
Jyoti A; Plano A; Riedel G; Platt B
Neurobiol Aging; 2015 Oct; 36(10):2768-84. PubMed ID: 26239174
[TBL] [Abstract][Full Text] [Related]
13. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes.
van Heusden FC; van Nifterick AM; Souza BC; França ASC; Nauta IM; Stam CJ; Scheltens P; Smit AB; Gouw AA; van Kesteren RE
Alzheimers Res Ther; 2023 Aug; 15(1):142. PubMed ID: 37608393
[TBL] [Abstract][Full Text] [Related]
15. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
[TBL] [Abstract][Full Text] [Related]
16. Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.
Colby-Milley J; Cavanagh C; Jego S; Breitner JC; Quirion R; Adamantidis A
PLoS One; 2015; 10(6):e0130177. PubMed ID: 26076358
[TBL] [Abstract][Full Text] [Related]
17. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission.
Wisor JP; Edgar DM; Yesavage J; Ryan HS; McCormick CM; Lapustea N; Murphy GM
Neuroscience; 2005; 131(2):375-85. PubMed ID: 15708480
[TBL] [Abstract][Full Text] [Related]
18. Impaired hippocampal-cortical coupling but preserved local synchrony during sleep in APP/PS1 mice modeling Alzheimer's disease.
Zhurakovskaya E; Ishchenko I; Gureviciene I; Aliev R; Gröhn O; Tanila H
Sci Rep; 2019 Mar; 9(1):5380. PubMed ID: 30926900
[TBL] [Abstract][Full Text] [Related]
19. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
[TBL] [Abstract][Full Text] [Related]
20. [Reproduction,genotype identification and evaluation of APP/PS1 transgenic mice].
Tan L; Li HQ; Li YB; Liu W; Pang W; Jiang YG
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):111-114. PubMed ID: 29926672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
